Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2025 Earnings Call Transcript November 6, 2025
Xeris Biopharma Holdings, Inc. misses on earnings expectations. Reported EPS is $0.0035 EPS, expectations were $0.01.
Operator: Hello, everyone, and thank you for joining us today for the Xeris Biopharma Q3 2025 Earnings Conference Call. My name is Sami, and I’ll be coordinating your call today. [Operator Instructions] I’d now like to hand over to your host, Allison Wey, Senior Vice President of...
